"Antidepressive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.
| Descriptor ID |
D000928
|
| MeSH Number(s) |
D27.505.954.427.700.122
|
| Concept/Terms |
Antidepressive Agents- Antidepressive Agents
- Agents, Antidepressive
- Antidepressant Drugs
- Drugs, Antidepressant
- Antidepressants
|
Below are MeSH descriptors whose meaning is more general than "Antidepressive Agents".
Below are MeSH descriptors whose meaning is more specific than "Antidepressive Agents".
This graph shows the total number of publications written about "Antidepressive Agents" by people in this website by year, and whether "Antidepressive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 1 | 3 |
| 2013 | 4 | 1 | 5 |
| 2014 | 2 | 0 | 2 |
| 2015 | 2 | 2 | 4 |
| 2016 | 6 | 4 | 10 |
| 2017 | 62 | 28 | 90 |
| 2018 | 70 | 30 | 100 |
| 2019 | 22 | 10 | 32 |
| 2020 | 0 | 5 | 5 |
| 2021 | 3 | 6 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Antidepressive Agents" by people in Profiles.
-
Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario, Canada. JAMA Netw Open. 2021 08 02; 4(8):e2118441.
-
Can antidepressants unlock prescription of rimonabant in the fight against COVID-19? Mol Psychiatry. 2021 12; 26(12):7091-7092.
-
Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases. Pharmacopsychiatry. 2022 Jan; 55(1):40-47.
-
Antidepressants as antiviral drugs? Neuropsychopharmacol Hung. 2021 06 01; 23(2):240-248.
-
Trends in antidepressant prescribing in England - Author's reply. Lancet Psychiatry. 2021 06; 8(6):e16.
-
Withanone Ameliorates Stress Symptoms in Caenorhabditis Elegans by Acting through Serotonin Receptors. Pharmacopsychiatry. 2021 Sep; 54(5):215-223.
-
Patient access to chronic medications during the Covid-19 pandemic: Evidence from a comprehensive dataset of US insurance claims. PLoS One. 2021; 16(4):e0249453.
-
Increased Stress Resistance and Lifespan in Chaenorhabditis elegans Wildtype and Knockout Mutants-Implications for Depression Treatment by Medicinal Herbs. Molecules. 2021 Mar 24; 26(7).
-
Are Persons Treated with Antidepressants and/or Antipsychotics Possibly Better Protected against Severe COVID 19? Pharmacopsychiatry. 2021 05; 54(3):142-143.
-
Surging trends in prescriptions and costs of antidepressants in England amid COVID-19. Daru. 2021 Jun; 29(1):217-221.